查看購物車
  • English
  • Japanese
  • Korean
注射給藥市場規模及預測（2021-2031年），全球及區域佔有率、趨勢、成長機會分析報告：按設備類型、製劑、製劑包裝、最終用戶及地區分類
市場調查報告書
商品編碼
1938222

注射給藥市場規模及預測（2021-2031年），全球及區域佔有率、趨勢、成長機會分析報告：按設備類型、製劑、製劑包裝、最終用戶及地區分類

Injectable Drug Delivery Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Device Type, Formulation, Formulation Packaging, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 476 Pages | 訂單完成後即時交付

價格
根據我們最新的研究報告《注射藥物輸送市場預測：2031 年全球分析—按類型和最終用戶分類》，預計該市場將從 2024 年的 405.6 億美元成長到 2031 年的 708.4 億美元，2025 年至 2031 年的複合年成長率為 8.5%。這一成長歸因於全球慢性病的增加、對需要腸外生物製藥和單株抗體的需求激增，以及自行注射技術和以患者為中心的給藥裝置的技術進步。

注射給藥是指使用針頭或無針給藥裝置將藥物直接注射到患者體內。注射給藥為患者提供了一種快速、準確且穩定的治療藥物給藥方式。注射給藥是生物製藥、疫苗、胰島素產品、癌症化療藥物、急救藥物以及其他無法口服或其他傳統途徑給藥的藥物的重要給藥方式。未來幾年，用於人工智慧賦能的個人化治療、快速反應疫苗和基因編輯的脂質奈米顆粒注射劑，以及注射系統中可生物分解的聚合物和環保包裝的進步，預計將成為注射給藥市場的主要發展趨勢。

北美注射給藥市場分為美國、加拿大和墨西哥三個部分。受多種因素影響，北美注射給藥市場持續擴張。美國佔最大的市場佔有率，其次是加拿大。本節重點介紹眾多製藥公司在產品成分無菌填充方面的合作創新，以開發複雜的生物製藥，例如GLP-1療法。此外，羅氏/基因泰克和諾華等跨國公司已與B2B合作夥伴建立策略聯盟，共同開發用於癌症藥物（AvastinAvastinRituxan）的皮下給藥系統（自行注射Rituxan）。與靜脈注射相比，這些系統提高了患者的依從性，同時增強了藥物的生物利用度，並實現了居家給藥。醫療產業的這種協同效應，透過注重產品的使用者友善設計，為產品生命週期管理提供了高效的流程，並減輕了醫療保健系統的負擔。 Enable Injections公司的穿戴裝置就是一個顛覆性技術的例證。該公司能夠輸送高黏度生物製藥（高達 50 毫升），並與生物製藥公司合作，共同解決單株抗體給藥的關鍵挑戰，例如聚集和黏度問題。與製藥公司的合作為長期管理慢性疾病提供了可擴展的解決方案。除了 Enable Injections 之外，Capsugel Dosage Form Solutions (DFS) 也採用垂直整合的 B2B 模式。 Capsugel 正與製藥和營養保健品公司合作，利用 LIPIDEX 平台開發膠囊填充技術。該技術能夠快速且有效率地將製劑從臨床試驗階段推進到 FDA 認證設施中的大規模生產（例如，高安全等級的注射劑，如荷爾蒙）。

此外，BD Medical 致力於提升皮下注射技術。例如，該公司與 ten23 Health 合作開發支援 RFID 的預填充式注射器（可在填充和表面處理工程中追蹤產品），並與 BioCorp 合作開發其 UltraSafe Plus Passive NeedleGuard 的互聯版本（可對使用抗凝血劑的情況進行數位化監測）。 SHL Medical 的 Maggie 5.0 自動注射器採用針頭隔離技術，該公司正與一家專注於腫瘤治療的製藥公司合作，幫助其客製化給藥系統中使用的針頭規格，以確保高劑量療法的最佳給藥時限。 Credence MedSystems 提供其 Connect 系統，可對臨床試驗中使用的預填充式注射器進行遠端資料記錄。 Philips Medisize 是拜耳在多發性硬化症治療 BETACONNECT 平台上的合作夥伴，提供一款互聯自動注射器，可透過基於應用程式的患者活動追蹤功能提高患者的治療依從性。這些例子反映了一種協作生態系統，其中 CDMO 和醫療設備製造商共同開發相互的平台，從而在從研發到產品分銷的每個階段實現順利整合，最終在競爭激烈的美國市場中實現營運效率。

目錄

第1章執行摘要

  • 分析師市場展望
  • 市場吸引力

第2章：注射給藥市場概況

  • 價值鏈分析
  • 供應鏈分析
    • 製造商/供應商列表
    • 潛在客戶名單（最多 50 家公司）
  • 波特五力分析
  • PEST分析
  • 主要國家進出口分析（基於最接近的HS編碼）
    • 主要國家的進口分析
    • 主要國家的出口分析
  • 人工智慧（AI）的影響
  • 產品或技術藍圖
  • 永續發展與ESG趨勢
    • 環境趨勢
    • 社會趨勢
    • 管治趨勢
  • 法律規範

第3章 競爭情勢

  • 主要企業進行企業標竿分析
  • 市場集中度

4. 注射給藥市場－主要市場動態

  • 市場促進因素
    • 全球慢性病發生率上升
    • 需要腸外給藥的生物製藥和單株抗體的快速成長
    • 自行注射和以病人為中心的給藥裝置的技術進步
  • 市場限制
    • 高成本
    • 嚴格的監管要求和漫長的核准流程
    • 供應鏈脆弱性
  • 市場機遇
    • 使用長效注射藥物
    • 注射免疫療法在癌症治療中的作用日益增強
    • 改善心理健康結果
  • 未來趨勢
    • 利用人工智慧促進個人化醫療
    • 用於快速反應疫苗和基因編輯的脂質奈米顆粒注射劑的進展
    • 注射藥物系統中的可生物分解聚合物和環保包裝
  • 促進因素和抑制因素的影響

5. 注射給藥市場－全球市場分析

  • 注射給藥市場收入（2021-2031 年）
  • 注射給藥市場預測與分析

6. 注射式藥物輸送市場收入分析－依設備類型分類

  • 注射給藥市場預測與分析（依器械類型分類）
    • 傳統藥物輸送裝置
      • 傳統給藥裝置：注射給藥市場 - 收入，2021-2031 年
    • 先進藥物傳輸裝置
      • 先進藥物輸送裝置：注射藥物輸送市場－收入，2021-2031年

7. 注射藥物遞送市場收入分析－按劑型分類

  • 注射劑藥物遞送市場預測及製劑分析
    • 傳統藥物遞送
      • 傳統藥物傳遞：注射市場 - 收入，2021-2031 年
    • 新型藥物遞送
      • 新型藥物遞送：注射劑市場－收入，2021-2031年
    • 長效注射劑

8. 注射藥物傳輸市場收入分析－藥品包裝

  • 注射劑市場預測與分析（依製劑包裝分類）
    • 安瓿
      • 安瓿：注射給藥市場 - 收入，2021-2031 年
    • 管瓶
      • 管瓶：注射給藥市場 - 收入，2021-2031 年
    • 墨水匣
      • 注射劑市場：注射給藥市場－收入，2021-2031年
    • 瓶子
      • 注射劑市場：2021-2031年收入

9. 注射給藥市場收入分析－依治療用途分類

  • 按治療應用分類的注射藥物傳輸市場預測與分析
    • 糖尿病
      • 糖尿病：注射藥物輸送市場－收入，2021-2031年
    • 腫瘤學
      • 腫瘤學：注射給藥市場－收入，2021-2031年
    • 自體免疫疾病
      • 自體免疫疾病：注射給藥市場－收入，2021-2031年
    • 心血管疾病
      • 循環系統疾病：注射給藥市場－收入，2021-2031年
    • 感染疾病
      • 感染疾病：注射給藥市場 - 收入，2021-2031 年
    • 疼痛管理
      • 疼痛管理：注射藥物傳輸市場－收入，2021-2031年
    • 其他治療用途
      • 其他治療用途：注射給藥市場 - 收入，2021-2031 年

10. 注射給藥市場收入分析－依給藥途徑分類

  • 按給藥途徑分類的注射給藥市場預測與分析
    • 皮下
      • 皮下給藥：注射藥物輸送市場－收入，2021-2031年
    • 肌肉內注射
      • 肌肉注射：注射給藥市場 - 收入，2021-2031 年
    • 靜脈
      • 靜脈注射：注射給藥市場 - 收入，2021-2031 年
    • 其他給藥途徑
      • 其他給藥途徑：注射給藥市場－收入，2021-2031年

第11章 注射給藥市場收入分析－按應用領域分類

  • 注射給藥市場：按用途和性別分類的預測和分析
    • 一次性注射器
      • 一次性注射器：注射給藥市場－收入，2021-2031年
    • 可重複使用的注射器
      • 可重複使用注射器：注射給藥市場－收入，2021-2031年

12. 注射給藥市場收入分析－以最終用戶分類

  • 注射給藥市場預測及最終用戶分析
    • 製藥和生物製藥公司
      • 製藥和生物製藥公司：注射給藥市場－收入，2021-2031年
    • CMO 和 CDMO
      • CMO 和 CDMO：注射藥物遞送市場 - 收入，2021-2031 年

13. 注射給藥市場－區域分析

  • 北美洲
    • 依設備類型
    • 按設備類型分類的先進藥物傳輸設備
    • 配方
    • 按劑型：常規藥物遞送
    • 新型藥物遞送系統製劑
    • 藥品包裝
    • 治療用途
    • 給藥途徑
    • 易用性
    • 最終用戶
    • 美國市場
    • 加拿大市場
    • 墨西哥市場
  • 歐洲
    • 德國市場
    • 英國市場
    • 法國市場
    • 西班牙市場
    • 義大利市場
    • 其他歐洲市場
  • 亞太地區
    • 中國市場
    • 日本市場
    • 印度市場
    • 澳洲市場
    • 韓國市場
    • 亞太地區的其他國家
  • 中東和非洲
    • 沙烏地阿拉伯市場
    • 南非市場
    • 阿拉伯聯合大公國市場
    • 其他中東和非洲市場
  • 南美洲和中美洲
    • 巴西市場
    • 阿根廷市場
    • 其他南美洲和中美洲及其他區域市場

第14章：注射給藥市場產業概況

15. 注射給藥市場－主要企業概況

  • Cardinal Health Inc
  • Becton Dickinson and Co
  • Schott AG
  • B Braun SE
  • Terumo Corp
  • Phillips-Medisize
  • Nipro Corp
  • Gerresheimer AG
  • Kindeva Drug Delivery LP
  • West Pharmaceutical Services Inc

第16章：待分析的其他公司名單

  • 待分析的其他公司名單

第17章附錄

Product Code: TIPRE00004204

According to our new research study on "Injectable Drug Delivery Market Forecast to 2031 -Global Analysis - by Type, and End User," the market is anticipated to grow from US$ 40.56 billion in 2024 to US$ 70.84 billion by 2031; the market is expected to register a CAGR of 8.5% from 2025 to 2031. The injectable drug delivery market growth is attributed to the rising global burden of chronic diseases, surge in biologics and monoclonal antibodies requiring parenteral administration, and technological advancements in self-injection and patient-centric delivery devices.

The delivery of drugs via injection involves administering drugs through the use of needles or needle-free delivery devices directly into the patient's body. Injectables provide a quick, accurate, and consistent means of administering therapeutic agents to patients. Injectables are an important delivery method for biologics, vaccinations, insulin products, cancer chemotherapy agents, emergency medications, and other medications that cannot be delivered in oral or other traditional routes. AI-driven personalization, advancing lipid nanoparticle injectables for rapid-response vaccines and gene editing, and biodegradable polymers and green packaging in injectable drug systems are expected to be major injectable drug delivery market trends in the coming years.

The injectable drug delivery market in North America is segmented into the US, Canada, and Mexico. The North America injectable drug delivery market is expanding owing to several factors. The US holds the largest market share, followed by Canada. The collaborative innovation in sterile filling and finishing of product components between many of the pharmaceutical companies in order to establish complex biological products like the GLP-1 therapies will be the main focus of this section. In addition, multi-national companies, such as Roche/Genentech and Novartis, have established strategic partnerships with their B2B partners to create subcutaneous delivery systems (self-injectable formats) for oncology drugs (Avastin, Rituxan) that are more user-friendly than intravenous routes, which limit patient compliance, while at the same time increasing the bioavailability of the drug to the patient, allowing them to administer the product at home. This synergy within the healthcare industry provides an efficient process for managing product life-cycles and reduces the burden on the healthcare system by focusing on the user-friendly designs of these products. An example of disruptive technology is Enable Injections' wearable devices that can administer large volumes (up to 50 mL) of viscous biological therapies, which work with biopharmaceutical companies to address key issues of aggregation and viscosity found in monoclonal antibody delivery. This collaboration with pharmaceutical companies provides a means to create scalable solutions to the long-term management of chronic diseases. In addition to Enable Injections, Capsugel Dosage Form Solutions (DFS) also maintains a vertically integrated B2B model. Capsugel collaborates with pharmaceutical and nutritional companies to design encapsulated liquid filling technology through the use of their LIPIDEX platform, providing both rapid and efficient formulations from clinical testing to large-scale production via FDA accredited sites for high containment injectables (i.e., hormones).

Additionally, BD Medical is enhancing the ability to inject beneath the skin through collaborations like its partnership with ten23 health for developing RFID-enabled pre-filled syringes that allow the tracking of products during filling and finishing stages and with Biocorp to create a connected version of the UltraSafe Plus Passive Needle Guard, which will enable the monitoring of patients' use of anticoagulants digitally. The Maggie 5.0 Autoinjector from SHL Medical includes Needle Isolation Technology and is working with oncology-focused pharmaceutical companies to help them customize the gauge used in the delivery system to ensure the best possible timeframes for delivering high doses of Therapeutics. Credence MedSystems offers the Connect system, which allows for remote data logging for prefilled syringes used in clinical studies. Phillips-Medisize is a partner of Bayer on the BETACONNECT platform for treating multiple sclerosis, through which they provide connected auto-injectors that enable a patient's adherence to the treatment by using an app to track the patient's activity. These examples reflect an ecosystem of collaboration between CDMOs and medical device manufacturers who develop each other's platforms together, which allow for smooth integration throughout the various steps required in going from R&D to putting products into distribution, ultimately resulting in increased operational efficiencies within the competitive landscape of the US.

The US Food and Drug Administration, World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization) are among the primary and secondary sources referred to while preparing the injectable drug delivery market report.

Table Of Contents

1. Executive Summary

  • 1.1 Analyst Market Outlook
  • 1.2 Market Attractiveness

2. Injectable Drug Delivery Market Landscape

  • 2.1 Overview
  • 2.2 Value Chain Analysis
  • 2.3 Supply Chain Analysis
    • 2.3.1 List of Manufacturers/Suppliers
    • 2.3.2 List of Potential Customers (Upto 50)
  • 2.4 Porter's Five Force Analysis
  • 2.5 PEST Analysis
  • 2.6 Import-Export Analysis for Key Countries (As per the nearest HS Code)
    • 2.6.1 Import Analysis for Key Countries
    • 2.6.2 Export Analysis for Key Countries
  • 2.7 Impact of Artificial Intelligence (AI)
  • 2.8 Product or Technology Roadmap
  • 2.9 Sustainability and ESG Trends
    • 2.9.1 Environmental Trends
    • 2.9.2 Social Trends
    • 2.9.3 Governance Trends
  • 2.10 Regulatory Framework

3. Competitive Landscape

  • 3.1 Company Benchmarking by Key Players
  • 3.2 Market Concentration

4. Injectable Drug Delivery Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Global Burden of Chronic Diseases
    • 4.1.2 Surge in Biologics and Monoclonal Antibodies Requiring Parenteral Administration
    • 4.1.3 Technological Advancements in Self-Injection and Patient-Centric Delivery Devices
  • 4.2 Market Restraints
    • 4.2.1 High Costs Associated with Manufacturing and Development
    • 4.2.2 Stringent Regulatory Requirements and Protracted Approval Processes
    • 4.2.3 Vulnerabilities in Supply Chains
  • 4.3 Market Opportunities
    • 4.3.1 Harnessing Long-Acting Injectables
    • 4.3.2 Expanding Role of Injectable Immunotherapies in Cancer Treatment
    • 4.3.3 Enhancing Mental Health Outcomes
  • 4.4 Future Trends
    • 4.4.1 AI-Driven Personalization
    • 4.4.2 Advancing Lipid Nanoparticle Injectables for Rapid-Response Vaccines and Gene Editing
    • 4.4.3 Biodegradable Polymers and Green Packaging in Injectable Drug Systems
  • 4.5 Impact of Drivers and Restraints

5. Injectable Drug Delivery Market - Global Market Analysis

  • 5.1 Injectable Drug Delivery Market Revenue (US$ Million), 2021-2031
  • 5.2 Injectable Drug Delivery Market Forecast and Analysis

6. Injectable Drug Delivery Market Revenue Analysis -Device Type

  • 6.1 Injectable Drug Delivery Market Forecasts and Analysis by Device Type
    • 6.1.1 Conventional Drug Delivery Devices
      • 6.1.1.1 Overview
      • 6.1.1.2 Conventional Drug Delivery Devices: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
    • 6.1.2 Advanced Drug Delivery Devices
      • 6.1.2.1 Overview
      • 6.1.2.2 Advanced Drug Delivery Devices: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)

7. Injectable Drug Delivery Market Revenue Analysis -Formulation

  • 7.1 Injectable Drug Delivery Market Forecasts and Analysis by Formulation
    • 7.1.1 Conventional Drug Delivery
      • 7.1.1.1 Overview
      • 7.1.1.2 Conventional Drug Delivery: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
    • 7.1.2 Novel Drug Delivery
      • 7.1.2.1 Overview
      • 7.1.2.2 Novel Drug Delivery: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
    • 7.1.3 Long Acting Injectable Formulations
      • 7.1.3.1 Overview

8. Injectable Drug Delivery Market Revenue Analysis -Formulation Packaging

  • 8.1 Injectable Drug Delivery Market Forecasts and Analysis by Formulation Packaging
    • 8.1.1 Ampoules
      • 8.1.1.1 Overview
      • 8.1.1.2 Ampoules: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
    • 8.1.2 Vials
      • 8.1.2.1 Overview
      • 8.1.2.2 Vials: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
    • 8.1.3 Cartridges
      • 8.1.3.1 Overview
      • 8.1.3.2 Cartridges: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
    • 8.1.4 Bottles
      • 8.1.4.1 Overview
      • 8.1.4.2 Bottles: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)

9. Injectable Drug Delivery Market Revenue Analysis -Therapeutic Application

  • 9.1 Injectable Drug Delivery Market Forecasts and Analysis by Therapeutic Application
    • 9.1.1 Diabetes
      • 9.1.1.1 Overview
      • 9.1.1.2 Diabetes: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
    • 9.1.2 Oncology
      • 9.1.2.1 Overview
      • 9.1.2.2 Oncology: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
    • 9.1.3 Auto-Immune Disorders
      • 9.1.3.1 Overview
      • 9.1.3.2 Auto-Immune Disorders: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
    • 9.1.4 Cardiovascular Diseases
      • 9.1.4.1 Overview
      • 9.1.4.2 Cardiovascular Diseases: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
    • 9.1.5 Infectious Diseases
      • 9.1.5.1 Overview
      • 9.1.5.2 Infectious Diseases: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
    • 9.1.6 Pain Management
      • 9.1.6.1 Overview
      • 9.1.6.2 Pain Management: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
    • 9.1.7 Other Therapeutic Application
      • 9.1.7.1 Overview
      • 9.1.7.2 Other Therapeutic Application: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)

10. Injectable Drug Delivery Market Revenue Analysis -Route Of Administration

  • 10.1 Injectable Drug Delivery Market Forecasts and Analysis by Route Of Administration
    • 10.1.1 Sub-cutaneous
      • 10.1.1.1 Overview
      • 10.1.1.2 Sub-cutaneous: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
    • 10.1.2 Intramuscular
      • 10.1.2.1 Overview
      • 10.1.2.2 Intramuscular: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
    • 10.1.3 Intravenous
      • 10.1.3.1 Overview
      • 10.1.3.2 Intravenous: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
    • 10.1.4 Other Route of Administration
      • 10.1.4.1 Overview
      • 10.1.4.2 Other Route of Administration: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)

11. Injectable Drug Delivery Market Revenue Analysis -Usability

  • 11.1 Injectable Drug Delivery Market Forecasts and Analysis by Usability
    • 11.1.1 Disposable Injectors
      • 11.1.1.1 Overview
      • 11.1.1.2 Disposable Injectors: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
    • 11.1.2 Re-usable Injectors
      • 11.1.2.1 Overview
      • 11.1.2.2 Re-usable Injectors: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)

12. Injectable Drug Delivery Market Revenue Analysis -End User

  • 12.1 Injectable Drug Delivery Market Forecasts and Analysis by End User
    • 12.1.1 Pharmaceutical and Biopharma Companies
      • 12.1.1.1 Overview
      • 12.1.1.2 Pharmaceutical and Biopharma Companies: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)
    • 12.1.2 CMOs and CDMOs
      • 12.1.2.1 Overview
      • 12.1.2.2 CMOs and CDMOs: Injectable Drug Delivery Market -Revenue, 2021-2031 (US$ Million)

13. Injectable Drug Delivery Market - Geographical Analysis

  • 13.1 North America
    • 13.1.1 North America Injectable Drug Delivery Market Overview
    • 13.1.2 North America: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 13.1.3 North America: Injectable Drug Delivery Market- By Segmentation
      • 13.1.3.1 Device Type
      • 13.1.3.2 Advanced Drug Delivery Devices By Device Type
      • 13.1.3.3 Formulation
      • 13.1.3.4 Conventional Drug Delivery By Formulation
      • 13.1.3.5 Novel Drug Delivery By Formulation
      • 13.1.3.6 Formulation Packaging
      • 13.1.3.7 Therapeutic Application
      • 13.1.3.8 Route Of Administration
      • 13.1.3.9 Usability
      • 13.1.3.10 End User
    • 13.1.4 North America: Injectable Drug Delivery Market Breakdown by Countries
      • 13.1.4.1 United States Market
        • 13.1.4.1.1 United States: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.1.4.1.2 United States: Injectable Drug Delivery Market- By Segmentation
          • 13.1.4.1.2.1 Device Type
          • 13.1.4.1.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.1.4.1.2.3 Formulation
          • 13.1.4.1.2.4 Conventional Drug Delivery By Formulation
          • 13.1.4.1.2.5 Novel Drug Delivery By Formulation
          • 13.1.4.1.2.6 Formulation Packaging
          • 13.1.4.1.2.7 Therapeutic Application
          • 13.1.4.1.2.8 Route Of Administration
          • 13.1.4.1.2.9 Usability
          • 13.1.4.1.2.10 End User
      • 13.1.4.2 Canada Market
        • 13.1.4.2.1 Canada: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.1.4.2.2 Canada: Injectable Drug Delivery Market- By Segmentation
          • 13.1.4.2.2.1 Device Type
          • 13.1.4.2.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.1.4.2.2.3 Formulation
          • 13.1.4.2.2.4 Conventional Drug Delivery By Formulation
          • 13.1.4.2.2.5 Novel Drug Delivery By Formulation
          • 13.1.4.2.2.6 Formulation Packaging
          • 13.1.4.2.2.7 Therapeutic Application
          • 13.1.4.2.2.8 Route Of Administration
          • 13.1.4.2.2.9 Usability
          • 13.1.4.2.2.10 End User
      • 13.1.4.3 Mexico Market
        • 13.1.4.3.1 Mexico: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.1.4.3.2 Mexico: Injectable Drug Delivery Market- By Segmentation
          • 13.1.4.3.2.1 Device Type
          • 13.1.4.3.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.1.4.3.2.3 Formulation
          • 13.1.4.3.2.4 Conventional Drug Delivery By Formulation
          • 13.1.4.3.2.5 Novel Drug Delivery By Formulation
          • 13.1.4.3.2.6 Formulation Packaging
          • 13.1.4.3.2.7 Therapeutic Application
          • 13.1.4.3.2.8 Route Of Administration
          • 13.1.4.3.2.9 Usability
          • 13.1.4.3.2.10 End User
  • 13.2 Europe
    • 13.2.1 Europe Injectable Drug Delivery Market Overview
    • 13.2.2 Europe: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 13.2.3 Europe: Injectable Drug Delivery Market- By Segmentation
      • 13.2.3.1 Device Type
      • 13.2.3.2 Advanced Drug Delivery Devices By Device Type
      • 13.2.3.3 Formulation
      • 13.2.3.4 Conventional Drug Delivery By Formulation
      • 13.2.3.5 Novel Drug Delivery By Formulation
      • 13.2.3.6 Formulation Packaging
      • 13.2.3.7 Therapeutic Application
      • 13.2.3.8 Route Of Administration
      • 13.2.3.9 Usability
      • 13.2.3.10 End User
    • 13.2.4 Europe: Injectable Drug Delivery Market Breakdown by Countries
      • 13.2.4.1 Germany Market
        • 13.2.4.1.1 Germany: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.2.4.1.2 Germany: Injectable Drug Delivery Market- By Segmentation
          • 13.2.4.1.2.1 Device Type
          • 13.2.4.1.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.2.4.1.2.3 Formulation
          • 13.2.4.1.2.4 Conventional Drug Delivery By Formulation
          • 13.2.4.1.2.5 Novel Drug Delivery By Formulation
          • 13.2.4.1.2.6 Formulation Packaging
          • 13.2.4.1.2.7 Therapeutic Application
          • 13.2.4.1.2.8 Route Of Administration
          • 13.2.4.1.2.9 Usability
          • 13.2.4.1.2.10 End User
      • 13.2.4.2 United Kingdom Market
        • 13.2.4.2.1 United Kingdom: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.2.4.2.2 United Kingdom: Injectable Drug Delivery Market- By Segmentation
          • 13.2.4.2.2.1 Device Type
          • 13.2.4.2.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.2.4.2.2.3 Formulation
          • 13.2.4.2.2.4 Conventional Drug Delivery By Formulation
          • 13.2.4.2.2.5 Novel Drug Delivery By Formulation
          • 13.2.4.2.2.6 Formulation Packaging
          • 13.2.4.2.2.7 Therapeutic Application
          • 13.2.4.2.2.8 Route Of Administration
          • 13.2.4.2.2.9 Usability
          • 13.2.4.2.2.10 End User
      • 13.2.4.3 France Market
        • 13.2.4.3.1 France: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.2.4.3.2 France: Injectable Drug Delivery Market- By Segmentation
          • 13.2.4.3.2.1 Device Type
          • 13.2.4.3.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.2.4.3.2.3 Formulation
          • 13.2.4.3.2.4 Conventional Drug Delivery By Formulation
          • 13.2.4.3.2.5 Novel Drug Delivery By Formulation
          • 13.2.4.3.2.6 Formulation Packaging
          • 13.2.4.3.2.7 Therapeutic Application
          • 13.2.4.3.2.8 Route Of Administration
          • 13.2.4.3.2.9 Usability
          • 13.2.4.3.2.10 End User
      • 13.2.4.4 Spain Market
        • 13.2.4.4.1 Spain: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.2.4.4.2 Spain: Injectable Drug Delivery Market- By Segmentation
          • 13.2.4.4.2.1 Device Type
          • 13.2.4.4.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.2.4.4.2.3 Formulation
          • 13.2.4.4.2.4 Conventional Drug Delivery By Formulation
          • 13.2.4.4.2.5 Novel Drug Delivery By Formulation
          • 13.2.4.4.2.6 Formulation Packaging
          • 13.2.4.4.2.7 Therapeutic Application
          • 13.2.4.4.2.8 Route Of Administration
          • 13.2.4.4.2.9 Usability
          • 13.2.4.4.2.10 End User
      • 13.2.4.5 Italy Market
        • 13.2.4.5.1 Italy: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.2.4.5.2 Italy: Injectable Drug Delivery Market- By Segmentation
          • 13.2.4.5.2.1 Device Type
          • 13.2.4.5.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.2.4.5.2.3 Formulation
          • 13.2.4.5.2.4 Conventional Drug Delivery By Formulation
          • 13.2.4.5.2.5 Novel Drug Delivery By Formulation
          • 13.2.4.5.2.6 Formulation Packaging
          • 13.2.4.5.2.7 Therapeutic Application
          • 13.2.4.5.2.8 Route Of Administration
          • 13.2.4.5.2.9 Usability
          • 13.2.4.5.2.10 End User
      • 13.2.4.6 Rest of Europe Market
        • 13.2.4.6.1 Rest of Europe: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.2.4.6.2 Rest of Europe: Injectable Drug Delivery Market- By Segmentation
          • 13.2.4.6.2.1 Device Type
          • 13.2.4.6.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.2.4.6.2.3 Formulation
          • 13.2.4.6.2.4 Conventional Drug Delivery By Formulation
          • 13.2.4.6.2.5 Novel Drug Delivery By Formulation
          • 13.2.4.6.2.6 Formulation Packaging
          • 13.2.4.6.2.7 Therapeutic Application
          • 13.2.4.6.2.8 Route Of Administration
          • 13.2.4.6.2.9 Usability
          • 13.2.4.6.2.10 End User
  • 13.3 Asia Pacific
    • 13.3.1 Asia Pacific Injectable Drug Delivery Market Overview
    • 13.3.2 Asia Pacific: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 13.3.3 Asia Pacific: Injectable Drug Delivery Market- By Segmentation
      • 13.3.3.1 Device Type
      • 13.3.3.2 Advanced Drug Delivery Devices By Device Type
      • 13.3.3.3 Formulation
      • 13.3.3.4 Conventional Drug Delivery By Formulation
      • 13.3.3.5 Novel Drug Delivery By Formulation
      • 13.3.3.6 Formulation Packaging
      • 13.3.3.7 Therapeutic Application
      • 13.3.3.8 Route Of Administration
      • 13.3.3.9 Usability
      • 13.3.3.10 End User
    • 13.3.4 Asia Pacific: Injectable Drug Delivery Market Breakdown by Countries
      • 13.3.4.1 China Market
        • 13.3.4.1.1 China: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.3.4.1.2 China: Injectable Drug Delivery Market- By Segmentation
          • 13.3.4.1.2.1 Device Type
          • 13.3.4.1.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.3.4.1.2.3 Formulation
          • 13.3.4.1.2.4 Conventional Drug Delivery By Formulation
          • 13.3.4.1.2.5 Novel Drug Delivery By Formulation
          • 13.3.4.1.2.6 Formulation Packaging
          • 13.3.4.1.2.7 Therapeutic Application
          • 13.3.4.1.2.8 Route Of Administration
          • 13.3.4.1.2.9 Usability
          • 13.3.4.1.2.10 End User
      • 13.3.4.2 Japan Market
        • 13.3.4.2.1 Japan: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.3.4.2.2 Japan: Injectable Drug Delivery Market- By Segmentation
          • 13.3.4.2.2.1 Device Type
          • 13.3.4.2.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.3.4.2.2.3 Formulation
          • 13.3.4.2.2.4 Conventional Drug Delivery By Formulation
          • 13.3.4.2.2.5 Novel Drug Delivery By Formulation
          • 13.3.4.2.2.6 Formulation Packaging
          • 13.3.4.2.2.7 Therapeutic Application
          • 13.3.4.2.2.8 Route Of Administration
          • 13.3.4.2.2.9 Usability
          • 13.3.4.2.2.10 End User
      • 13.3.4.3 India Market
        • 13.3.4.3.1 India: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.3.4.3.2 India: Injectable Drug Delivery Market- By Segmentation
          • 13.3.4.3.2.1 Device Type
          • 13.3.4.3.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.3.4.3.2.3 Formulation
          • 13.3.4.3.2.4 Conventional Drug Delivery By Formulation
          • 13.3.4.3.2.5 Novel Drug Delivery By Formulation
          • 13.3.4.3.2.6 Formulation Packaging
          • 13.3.4.3.2.7 Therapeutic Application
          • 13.3.4.3.2.8 Route Of Administration
          • 13.3.4.3.2.9 Usability
          • 13.3.4.3.2.10 End User
      • 13.3.4.4 Australia Market
        • 13.3.4.4.1 Australia: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.3.4.4.2 Australia: Injectable Drug Delivery Market- By Segmentation
          • 13.3.4.4.2.1 Device Type
          • 13.3.4.4.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.3.4.4.2.3 Formulation
          • 13.3.4.4.2.4 Conventional Drug Delivery By Formulation
          • 13.3.4.4.2.5 Novel Drug Delivery By Formulation
          • 13.3.4.4.2.6 Formulation Packaging
          • 13.3.4.4.2.7 Therapeutic Application
          • 13.3.4.4.2.8 Route Of Administration
          • 13.3.4.4.2.9 Usability
          • 13.3.4.4.2.10 End User
      • 13.3.4.5 South Korea Market
        • 13.3.4.5.1 South Korea: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.3.4.5.2 South Korea: Injectable Drug Delivery Market- By Segmentation
          • 13.3.4.5.2.1 Device Type
          • 13.3.4.5.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.3.4.5.2.3 Formulation
          • 13.3.4.5.2.4 Conventional Drug Delivery By Formulation
          • 13.3.4.5.2.5 Novel Drug Delivery By Formulation
          • 13.3.4.5.2.6 Formulation Packaging
          • 13.3.4.5.2.7 Therapeutic Application
          • 13.3.4.5.2.8 Route Of Administration
          • 13.3.4.5.2.9 Usability
          • 13.3.4.5.2.10 End User
      • 13.3.4.6 Rest of APAC Market
        • 13.3.4.6.1 Rest of APAC: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.3.4.6.2 Rest of APAC: Injectable Drug Delivery Market- By Segmentation
          • 13.3.4.6.2.1 Device Type
          • 13.3.4.6.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.3.4.6.2.3 Formulation
          • 13.3.4.6.2.4 Conventional Drug Delivery By Formulation
          • 13.3.4.6.2.5 Novel Drug Delivery By Formulation
          • 13.3.4.6.2.6 Formulation Packaging
          • 13.3.4.6.2.7 Therapeutic Application
          • 13.3.4.6.2.8 Route Of Administration
          • 13.3.4.6.2.9 Usability
          • 13.3.4.6.2.10 End User
  • 13.4 Middle East and Africa
    • 13.4.1 Middle East and Africa Injectable Drug Delivery Market Overview
    • 13.4.2 Middle East and Africa: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 13.4.3 Middle East and Africa: Injectable Drug Delivery Market- By Segmentation
      • 13.4.3.1 Device Type
      • 13.4.3.2 Advanced Drug Delivery Devices By Device Type
      • 13.4.3.3 Formulation
      • 13.4.3.4 Conventional Drug Delivery By Formulation
      • 13.4.3.5 Novel Drug Delivery By Formulation
      • 13.4.3.6 Formulation Packaging
      • 13.4.3.7 Therapeutic Application
      • 13.4.3.8 Route Of Administration
      • 13.4.3.9 Usability
      • 13.4.3.10 End User
    • 13.4.4 Middle East and Africa: Injectable Drug Delivery Market Breakdown by Countries
      • 13.4.4.1 Saudi Arabia Market
        • 13.4.4.1.1 Saudi Arabia: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.4.4.1.2 Saudi Arabia: Injectable Drug Delivery Market- By Segmentation
          • 13.4.4.1.2.1 Device Type
          • 13.4.4.1.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.4.4.1.2.3 Formulation
          • 13.4.4.1.2.4 Conventional Drug Delivery By Formulation
          • 13.4.4.1.2.5 Novel Drug Delivery By Formulation
          • 13.4.4.1.2.6 Formulation Packaging
          • 13.4.4.1.2.7 Therapeutic Application
          • 13.4.4.1.2.8 Route Of Administration
          • 13.4.4.1.2.9 Usability
          • 13.4.4.1.2.10 End User
      • 13.4.4.2 South Africa Market
        • 13.4.4.2.1 South Africa: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.4.4.2.2 South Africa: Injectable Drug Delivery Market- By Segmentation
          • 13.4.4.2.2.1 Device Type
          • 13.4.4.2.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.4.4.2.2.3 Formulation
          • 13.4.4.2.2.4 Conventional Drug Delivery By Formulation
          • 13.4.4.2.2.5 Novel Drug Delivery By Formulation
          • 13.4.4.2.2.6 Formulation Packaging
          • 13.4.4.2.2.7 Therapeutic Application
          • 13.4.4.2.2.8 Route Of Administration
          • 13.4.4.2.2.9 Usability
          • 13.4.4.2.2.10 End User
      • 13.4.4.3 United Arab Emirates Market
        • 13.4.4.3.1 United Arab Emirates: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.4.4.3.2 United Arab Emirates: Injectable Drug Delivery Market- By Segmentation
          • 13.4.4.3.2.1 Device Type
          • 13.4.4.3.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.4.4.3.2.3 Formulation
          • 13.4.4.3.2.4 Conventional Drug Delivery By Formulation
          • 13.4.4.3.2.5 Novel Drug Delivery By Formulation
          • 13.4.4.3.2.6 Formulation Packaging
          • 13.4.4.3.2.7 Therapeutic Application
          • 13.4.4.3.2.8 Route Of Administration
          • 13.4.4.3.2.9 Usability
          • 13.4.4.3.2.10 End User
      • 13.4.4.4 Rest of Middle East and Africa Market
        • 13.4.4.4.1 Rest of Middle East and Africa: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.4.4.4.2 Rest of Middle East and Africa: Injectable Drug Delivery Market- By Segmentation
          • 13.4.4.4.2.1 Device Type
          • 13.4.4.4.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.4.4.4.2.3 Formulation
          • 13.4.4.4.2.4 Conventional Drug Delivery By Formulation
          • 13.4.4.4.2.5 Novel Drug Delivery By Formulation
          • 13.4.4.4.2.6 Formulation Packaging
          • 13.4.4.4.2.7 Therapeutic Application
          • 13.4.4.4.2.8 Route Of Administration
          • 13.4.4.4.2.9 Usability
          • 13.4.4.4.2.10 End User
  • 13.5 South and Central America
    • 13.5.1 South and Central America Injectable Drug Delivery Market Overview
    • 13.5.2 South and Central America: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 13.5.3 South and Central America: Injectable Drug Delivery Market- By Segmentation
      • 13.5.3.1 Device Type
      • 13.5.3.2 Advanced Drug Delivery Devices By Device Type
      • 13.5.3.3 Formulation
      • 13.5.3.4 Conventional Drug Delivery By Formulation
      • 13.5.3.5 Novel Drug Delivery By Formulation
      • 13.5.3.6 Formulation Packaging
      • 13.5.3.7 Therapeutic Application
      • 13.5.3.8 Route Of Administration
      • 13.5.3.9 Usability
      • 13.5.3.10 End User
    • 13.5.4 South and Central America: Injectable Drug Delivery Market Breakdown by Countries
      • 13.5.4.1 Brazil Market
        • 13.5.4.1.1 Brazil: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.5.4.1.2 Brazil: Injectable Drug Delivery Market- By Segmentation
          • 13.5.4.1.2.1 Device Type
          • 13.5.4.1.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.5.4.1.2.3 Formulation
          • 13.5.4.1.2.4 Conventional Drug Delivery By Formulation
          • 13.5.4.1.2.5 Novel Drug Delivery By Formulation
          • 13.5.4.1.2.6 Formulation Packaging
          • 13.5.4.1.2.7 Therapeutic Application
          • 13.5.4.1.2.8 Route Of Administration
          • 13.5.4.1.2.9 Usability
          • 13.5.4.1.2.10 End User
      • 13.5.4.2 Argentina Market
        • 13.5.4.2.1 Argentina: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.5.4.2.2 Argentina: Injectable Drug Delivery Market- By Segmentation
          • 13.5.4.2.2.1 Device Type
          • 13.5.4.2.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.5.4.2.2.3 Formulation
          • 13.5.4.2.2.4 Conventional Drug Delivery By Formulation
          • 13.5.4.2.2.5 Novel Drug Delivery By Formulation
          • 13.5.4.2.2.6 Formulation Packaging
          • 13.5.4.2.2.7 Therapeutic Application
          • 13.5.4.2.2.8 Route Of Administration
          • 13.5.4.2.2.9 Usability
          • 13.5.4.2.2.10 End User
      • 13.5.4.3 Rest of South and Central America Market
        • 13.5.4.3.1 Rest of South and Central America: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 13.5.4.3.2 Rest of South and Central America: Injectable Drug Delivery Market- By Segmentation
          • 13.5.4.3.2.1 Device Type
          • 13.5.4.3.2.2 Advanced Drug Delivery Devices By Device Type
          • 13.5.4.3.2.3 Formulation
          • 13.5.4.3.2.4 Conventional Drug Delivery By Formulation
          • 13.5.4.3.2.5 Novel Drug Delivery By Formulation
          • 13.5.4.3.2.6 Formulation Packaging
          • 13.5.4.3.2.7 Therapeutic Application
          • 13.5.4.3.2.8 Route Of Administration
          • 13.5.4.3.2.9 Usability
          • 13.5.4.3.2.10 End User

14. Injectable Drug Delivery Market Industry Landscape

15. Injectable Drug Delivery Market - Key Company Profiles

  • 15.1 Cardinal Health Inc
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 Becton Dickinson and Co
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 Schott AG
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 B Braun SE
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments
  • 15.5 Terumo Corp
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 Phillips-Medisize
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 Nipro Corp
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Products and Services
    • 15.7.4 Financial Overview
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments
  • 15.8 Gerresheimer AG
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Products and Services
    • 15.8.4 Financial Overview
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 Kindeva Drug Delivery LP
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Products and Services
    • 15.9.4 Financial Overview
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 West Pharmaceutical Services Inc
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Products and Services
    • 15.10.4 Financial Overview
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments

16. List of Additional Companies Analyzed

  • 16.1 List of Additional Companies Analyzed

17. Appendix

  • 17.1 Glossary
  • 17.2 Research Methodology and Approach
    • 17.2.1 Secondary Research
    • 17.2.2 Primary Research
    • 17.2.3 Market Estimation Approach
      • 17.2.3.1 Supply Side Analysis
      • 17.2.3.2 Demand Side Analysis
    • 17.2.4 Research Assumptions and Limitations
    • 17.2.5 Currency Conversion
  • 17.3 About The Insight Partners
  • 17.4 Market Intelligence Cloud

List Of Tables

  • Table 1. Injectable Drug Delivery Market Segmentation. 2
  • Table 2. List of Regulatory Bodies and Organizations
  • Table 3. Ease of Doing Business: Key Country Rankings
  • Table 4. Injectable Drug Delivery Market - Revenue, 2021-2024(US$ Million)
  • Table 5. Injectable Drug Delivery Market - Revenue Forecast, 2025-2031(US$ Million)
  • Table 6. Injectable Drug Delivery Market - Revenue, 2021-2024(US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 7. Injectable Drug Delivery Market - Revenue Forecast, 2025-2031(US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 8. Injectable Drug Delivery Market - Revenue, 2021-2024(US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 9. Injectable Drug Delivery Market - Revenue Forecast, 2025-2031(US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 10. Injectable Drug Delivery Market - Revenue, 2021-2024(US$ Million) - by Novel Drug Delivery By Formulation
  • Table 11. Injectable Drug Delivery Market - Revenue Forecast, 2025-2031(US$ Million) - by Novel Drug Delivery By Formulation
  • Table 12. North America: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Device Type
  • Table 13. North America: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Device Type
  • Table 14. North America: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 15. North America: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 16. North America: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation
  • Table 17. North America: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation
  • Table 18. North America: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 19. North America: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 20. North America: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 21. North America: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 22. North America: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation Packaging
  • Table 23. North America: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation Packaging
  • Table 24. North America: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Application
  • Table 25. North America: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Application
  • Table 26. North America: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 27. North America: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 28. North America: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Usability
  • Table 29. North America: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Usability
  • Table 30. North America: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 31. North America: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 32. United States: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Device Type
  • Table 33. United States: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Device Type
  • Table 34. United States: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 35. United States: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 36. United States: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation
  • Table 37. United States: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation
  • Table 38. United States: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 39. United States: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 40. United States: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 41. United States: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 42. United States: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation Packaging
  • Table 43. United States: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation Packaging
  • Table 44. United States: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Application
  • Table 45. United States: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Application
  • Table 46. United States: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 47. United States: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 48. United States: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Usability
  • Table 49. United States: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Usability
  • Table 50. United States: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 51. United States: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 52. Canada: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Device Type
  • Table 53. Canada: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Device Type
  • Table 54. Canada: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 55. Canada: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 56. Canada: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation
  • Table 57. Canada: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation
  • Table 58. Canada: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 59. Canada: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 60. Canada: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 61. Canada: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 62. Canada: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation Packaging
  • Table 63. Canada: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation Packaging
  • Table 64. Canada: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Application
  • Table 65. Canada: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Application
  • Table 66. Canada: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 67. Canada: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 68. Canada: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Usability
  • Table 69. Canada: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Usability
  • Table 70. Canada: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 71. Canada: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 72. Mexico: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Device Type
  • Table 73. Mexico: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Device Type
  • Table 74. Mexico: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 75. Mexico: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 76. Mexico: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation
  • Table 77. Mexico: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation
  • Table 78. Mexico: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 79. Mexico: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 80. Mexico: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 81. Mexico: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 82. Mexico: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation Packaging
  • Table 83. Mexico: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation Packaging
  • Table 84. Mexico: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Application
  • Table 85. Mexico: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Application
  • Table 86. Mexico: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 87. Mexico: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 88. Mexico: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Usability
  • Table 89. Mexico: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Usability
  • Table 90. Mexico: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 91. Mexico: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 92. Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Device Type
  • Table 93. Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Device Type
  • Table 94. Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 95. Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 96. Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation
  • Table 97. Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation
  • Table 98. Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 99. Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 100. Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 101. Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 102. Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation Packaging
  • Table 103. Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation Packaging
  • Table 104. Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Application
  • Table 105. Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Application
  • Table 106. Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 107. Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 108. Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Usability
  • Table 109. Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Usability
  • Table 110. Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 111. Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 112. Germany: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Device Type
  • Table 113. Germany: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Device Type
  • Table 114. Germany: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 115. Germany: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 116. Germany: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation
  • Table 117. Germany: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation
  • Table 118. Germany: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 119. Germany: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 120. Germany: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 121. Germany: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 122. Germany: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation Packaging
  • Table 123. Germany: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation Packaging
  • Table 124. Germany: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Application
  • Table 125. Germany: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Application
  • Table 126. Germany: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 127. Germany: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 128. Germany: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Usability
  • Table 129. Germany: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Usability
  • Table 130. Germany: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 131. Germany: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 132. United Kingdom: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Device Type
  • Table 133. United Kingdom: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Device Type
  • Table 134. United Kingdom: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 135. United Kingdom: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 136. United Kingdom: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation
  • Table 137. United Kingdom: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation
  • Table 138. United Kingdom: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 139. United Kingdom: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 140. United Kingdom: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 141. United Kingdom: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 142. United Kingdom: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation Packaging
  • Table 143. United Kingdom: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation Packaging
  • Table 144. United Kingdom: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Application
  • Table 145. United Kingdom: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Application
  • Table 146. United Kingdom: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 147. United Kingdom: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 148. United Kingdom: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Usability
  • Table 149. United Kingdom: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Usability
  • Table 150. United Kingdom: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 151. United Kingdom: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 152. France: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Device Type
  • Table 153. France: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Device Type
  • Table 154. France: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 155. France: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 156. France: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation
  • Table 157. France: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation
  • Table 158. France: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 159. France: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 160. France: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 161. France: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 162. France: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation Packaging
  • Table 163. France: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation Packaging
  • Table 164. France: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Application
  • Table 165. France: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Application
  • Table 166. France: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 167. France: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 168. France: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Usability
  • Table 169. France: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Usability
  • Table 170. France: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 171. France: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 172. Spain: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Device Type
  • Table 173. Spain: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Device Type
  • Table 174. Spain: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 175. Spain: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 176. Spain: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation
  • Table 177. Spain: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation
  • Table 178. Spain: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 179. Spain: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 180. Spain: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 181. Spain: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 182. Spain: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation Packaging
  • Table 183. Spain: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation Packaging
  • Table 184. Spain: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Application
  • Table 185. Spain: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Application
  • Table 186. Spain: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 187. Spain: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 188. Spain: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Usability
  • Table 189. Spain: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Usability
  • Table 190. Spain: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 191. Spain: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 192. Italy: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Device Type
  • Table 193. Italy: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Device Type
  • Table 194. Italy: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 195. Italy: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 196. Italy: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation
  • Table 197. Italy: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation
  • Table 198. Italy: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 199. Italy: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 200. Italy: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 201. Italy: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 202. Italy: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation Packaging
  • Table 203. Italy: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation Packaging
  • Table 204. Italy: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Application
  • Table 205. Italy: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Application
  • Table 206. Italy: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 207. Italy: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 208. Italy: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Usability
  • Table 209. Italy: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Usability
  • Table 210. Italy: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 211. Italy: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 212. Rest of Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Device Type
  • Table 213. Rest of Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Device Type
  • Table 214. Rest of Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 215. Rest of Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 216. Rest of Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation
  • Table 217. Rest of Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation
  • Table 218. Rest of Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 219. Rest of Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 220. Rest of Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 221. Rest of Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 222. Rest of Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation Packaging
  • Table 223. Rest of Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation Packaging
  • Table 224. Rest of Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Application
  • Table 225. Rest of Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Application
  • Table 226. Rest of Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 227. Rest of Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 228. Rest of Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Usability
  • Table 229. Rest of Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Usability
  • Table 230. Rest of Europe: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 231. Rest of Europe: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 232. Asia Pacific: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Device Type
  • Table 233. Asia Pacific: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Device Type
  • Table 234. Asia Pacific: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 235. Asia Pacific: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 236. Asia Pacific: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation
  • Table 237. Asia Pacific: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation
  • Table 238. Asia Pacific: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 239. Asia Pacific: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 240. Asia Pacific: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 241. Asia Pacific: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 242. Asia Pacific: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation Packaging
  • Table 243. Asia Pacific: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation Packaging
  • Table 244. Asia Pacific: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Application
  • Table 245. Asia Pacific: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Application
  • Table 246. Asia Pacific: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 247. Asia Pacific: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 248. Asia Pacific: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Usability
  • Table 249. Asia Pacific: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Usability
  • Table 250. Asia Pacific: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 251. Asia Pacific: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 252. China: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Device Type
  • Table 253. China: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Device Type
  • Table 254. China: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 255. China: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Advanced Drug Delivery Devices By Device Type
  • Table 256. China: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation
  • Table 257. China: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation
  • Table 258. China: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 259. China: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Conventional Drug Delivery By Formulation
  • Table 260. China: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 261. China: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Novel Drug Delivery By Formulation
  • Table 262. China: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Formulation Packaging
  • Table 263. China: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Formulation Packaging
  • Table 264. China: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Application
  • Table 265. China: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Application
  • Table 266. China: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
  • Table 267. China: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
  • Table 268. China: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Usability
  • Table 269. China: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by Usability
  • Table 270. China: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 271. China: Injectable Drug Delivery Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 272. Japan: Injectable Drug Delivery Market - Revenue, 2021-2024 (US$ Million) - by Device Type
  • Table 273. Japan: Injectable

List Of Figures

  • Figure 1. Injectable Drug Delivery Market - Value Chain Analysis
  • Figure 2. Porter's Five Forces Analysis
  • Figure 3. Pest Analysis
  • Figure 4. Injectable Drug Delivery Market - Key Industry Dynamics
  • Figure 5. Impact Analysis of Drivers and Restraints
  • Figure 6. Injectable Drug Delivery Market Revenue (US$ Million), 2021-2031
  • Figure 7. Injectable Drug Delivery Market Share (%) - by Device Type (2024 and 2031)
  • Figure 8. Conventional Drug Delivery Devices: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 9. Advanced Drug Delivery Devices: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 10. Injectable Drug Delivery Market Share (%) - by Formulation (2024 and 2031)
  • Figure 11. Conventional Drug Delivery: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 12. Novel Drug Delivery: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 13. Long Acting Injectable Formulations: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 14. Injectable Drug Delivery Market Share (%) - by Formulation Packaging (2024 and 2031)
  • Figure 15. Ampoules: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 16. Vials: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 17. Cartridges: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 18. Bottles: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 19. Injectable Drug Delivery Market Share (%) - by Therapeutic Application (2024 and 2031)
  • Figure 20. Diabetes: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 21. Oncology: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 22. Auto-Immune Disorders: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 23. Cardiovascular Diseases: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 24. Infectious Diseases: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 25. Pain Management: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 26. Other Therapeutic Application: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 27. Injectable Drug Delivery Market Share (%) - by Route Of Administration (2024 and 2031)
  • Figure 28. Sub-cutaneous: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 29. Intramuscular: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 30. Intravenous: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 31. Other Route of Administration: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 32. Injectable Drug Delivery Market Share (%) - by Usability (2024 and 2031)
  • Figure 33. Disposable Injectors: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 34. Re-usable Injectors: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 35. Injectable Drug Delivery Market Share (%) - by End User (2024 and 2031)
  • Figure 36. Pharmaceutical and Biopharma Companies: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 37. CMOs and CDMOs: Injectable Drug Delivery Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 38. North America: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 39. North America: Injectable Drug Delivery Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 40. United States: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 41. Canada: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 42. Mexico: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 43. Europe: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 44. Europe: Injectable Drug Delivery Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 45. Germany: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 46. United Kingdom: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 47. France: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 48. Spain: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 49. Italy: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 50. Rest of Europe: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 51. Asia Pacific: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 52. Asia Pacific: Injectable Drug Delivery Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 53. China: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 54. Japan: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 55. India: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 56. Australia: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 57. South Korea: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 58. Rest of APAC: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 59. Middle East and Africa: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 60. Middle East and Africa: Injectable Drug Delivery Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 61. Saudi Arabia: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 62. South Africa: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 63. United Arab Emirates: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 64. Rest of Middle East and Africa: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 65. South and Central America: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 66. South and Central America: Injectable Drug Delivery Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 67. Brazil: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 68. Argentina: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 69. Rest of South and Central America: Injectable Drug Delivery Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 70. Bottom-Up Approach and Top-Down Approach